Skye Bioscience (SKYE) Shares Outstanding (2012 - 2026)

Skye Bioscience (SKYE) has reported Shares Outstanding (Entity) for 15 consecutive years, with $4.4 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Shares Outstanding (Entity) fell 11.39% year-over-year to $4.4 million in Q2 2026; TTM through Jun 2026 was $4.4 million, a 11.39% decrease from a year earlier, with the FY2025 full-year figure at $4.2 million, up 7.76% from the prior year.
• Shares Outstanding (Entity) was $4.4 million for Q2 2026 at Skye Bioscience, roughly flat from $4.4 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $5.0 million in Q3 2025 and troughed at $247963.0 in Q1 2022.
• A 5-year average of $2.7 million and a median of $3.7 million in 2024 frame the typical range for Shares Outstanding (Entity).
• Across the five-year window, Shares Outstanding (Entity) jumped 895.04% in 2024 and retreated 11.41% in 2026, its largest moves.
• Over 5 years, Shares Outstanding (Entity) stood at $277635.0 in 2022, then soared by 215.43% to $875755.0 in 2023, then soared by 342.11% to $3.9 million in 2024, then climbed by 7.76% to $4.2 million in 2025, then rose by 5.29% to $4.4 million in 2026.
• The last three Shares Outstanding (Entity) figures came in at $4.4 million (Q2 2026), $4.4 million (Q1 2026), and $4.2 million (Q4 2025), per Business Quant data.